{
  "id": 5242,
  "url": "https://nnemf.org/research/5242-exposure-to-900-mhz-electromagnetic-field-induces-an",
  "title": "Exposure to 900 MHz electromagnetic field induces an unbalance between pro-apoptotic and pro-survival signals in T-lymphoblastoid leukemia CCRF-CEM cells.",
  "authors": [
    "F Marinelli",
    "D La Sala",
    "G Cicciotti",
    "L Cattini",
    "C Trimarchi",
    "S Putti",
    "A Zamparelli",
    "L Giuliani",
    "G Tomassetti",
    "Caterina Cinti"
  ],
  "journal": "Journal of cellular physiology",
  "year": "2004",
  "doi": "10.1002/jcp.10425",
  "pmid": "14603534",
  "abstract": "It has been recently established that low-frequency electromagnetic field (EMFs) exposure induces biological changes and could be associated with increased incidence of cancer, while the issue remains unresolved as to whether high-frequency EMFs can have hazardous effect on health. Epidemiological studies on association between childhood cancers, particularly leukemia and brain cancer, and exposure to low- and high-frequency EMF suggested an etiological role of EMFs in inducing adverse health effects. To investigate whether exposure to high-frequency EMFs could affect in vitro cell survival, we cultured acute T-lymphoblastoid leukemia cells (CCRF-CEM) in the presence of unmodulated 900 MHz EMF, generated by a transverse electromagnetic (TEM) cell, at various exposure times. We evaluated the effects of high-frequency EMF on cell growth rate and apoptosis induction, by cell viability (MTT) test, FACS analysis and DNA ladder, and we investigated pro-apoptotic and pro-survival signaling pathways possibly involved as a function of exposure time by Western blot analysis. At short exposure times (2-12 h), unmodulated 900 MHz EMF induced DNA breaks and early activation of both p53-dependent and -independent apoptotic pathways while longer continuous exposure (24-48 h) determined silencing of pro-apoptotic signals and activation of genes involved in both intracellular (Bcl-2) and extracellular (Ras and Akt1) pro-survival signaling. Overall our results indicate that exposure to 900 MHz continuous wave, after inducing an early self-defense response triggered by DNA damage, could confer to the survivor CCRF-CEM cells a further advantage to survive and proliferate.",
  "effect": "mixed",
  "evidence": "low",
  "extraction": {
    "studyType": "in_vitro",
    "studyTypeLabel": "In vitro study",
    "effectDirection": "mixed",
    "evidenceLabel": "Low",
    "population": "Acute T-lymphoblastoid leukemia cells (CCRF-CEM)",
    "sampleSize": "—",
    "exposure": "RF · 900 MHz · 2–48 h (short: 2–12 h; long: 24–48 h)",
    "confidencePct": "78",
    "peerReviewed": "yes",
    "mainFindings": "In CCRF-CEM cells exposed in vitro to unmodulated 900 MHz EMF, short exposures (2–12 h) induced DNA breaks and early activation of p53-dependent and p53-independent apoptotic pathways. Longer continuous exposure (24–48 h) was associated with silencing of pro-apoptotic signals and activation of pro-survival signaling (including Bcl-2, Ras, Akt1), which the authors interpret as conferring a survival/proliferation advantage to surviving cells.",
    "outcomes": [
      "Cell growth rate",
      "Cell viability (MTT)",
      "Apoptosis induction (FACS analysis",
      "DNA ladder)",
      "DNA breaks",
      "p53-dependent apoptotic pathway activation",
      "p53-independent apoptotic pathway activation",
      "Pro-apoptotic signaling (silencing at longer exposure)",
      "Pro-survival signaling (Bcl-2",
      "Ras",
      "Akt1 activation)"
    ],
    "limitations": [
      "In vitro cell-line study",
      "findings may not translate to in vivo or human health outcomes",
      "No dosimetry details reported in the abstract (e.g.",
      "SAR",
      "field strength)",
      "Sample size/replication not reported in the abstract"
    ],
    "keywords": [
      "900 MHz",
      "radiofrequency",
      "continuous wave",
      "unmodulated",
      "TEM cell",
      "CCRF-CEM",
      "T-lymphoblastoid leukemia",
      "apoptosis",
      "DNA damage",
      "p53",
      "Bcl-2",
      "Ras",
      "Akt1"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"in_vitro\",\n  \"exposure\": {\n    \"band\": \"RF\",\n    \"source\": null,\n    \"frequency_mhz\": 900,\n    \"sar_wkg\": null,\n    \"duration\": \"2–48 h (short: 2–12 h; long: 24–48 h)\"\n  },\n  \"population\": \"Acute T-lymphoblastoid leukemia cells (CCRF-CEM)\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"Cell growth rate\",\n    \"Cell viability (MTT)\",\n    \"Apoptosis induction (FACS analysis, DNA ladder)\",\n    \"DNA breaks\",\n    \"p53-dependent apoptotic pathway activation\",\n    \"p53-independent apoptotic pathway activation\",\n    \"Pro-apoptotic signaling (silencing at longer exposure)\",\n    \"Pro-survival signaling (Bcl-2, Ras, Akt1 activation)\"\n  ],\n  \"main_findings\": \"In CCRF-CEM cells exposed in vitro to unmodulated 900 MHz EMF, short exposures (2–12 h) induced DNA breaks and early activation of p53-dependent and p53-independent apoptotic pathways. Longer continuous exposure (24–48 h) was associated with silencing of pro-apoptotic signals and activation of pro-survival signaling (including Bcl-2, Ras, Akt1), which the authors interpret as conferring a survival/proliferation advantage to surviving cells.\",\n  \"effect_direction\": \"mixed\",\n  \"limitations\": [\n    \"In vitro cell-line study; findings may not translate to in vivo or human health outcomes\",\n    \"No dosimetry details reported in the abstract (e.g., SAR, field strength)\",\n    \"Sample size/replication not reported in the abstract\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.78,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"900 MHz\",\n    \"radiofrequency\",\n    \"continuous wave\",\n    \"unmodulated\",\n    \"TEM cell\",\n    \"CCRF-CEM\",\n    \"T-lymphoblastoid leukemia\",\n    \"apoptosis\",\n    \"DNA damage\",\n    \"p53\",\n    \"Bcl-2\",\n    \"Ras\",\n    \"Akt1\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/14603534/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=5242",
  "updated": "2026-02-14 08:16:13"
}